$78.25 -2.22 (%) Gilead Sciences Inc - NASDAQ

Jun. 27, 2016 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. The Stocks That Moved The S&P, Dow And Nasdaq Today

    Benzinga | Feb. 17, 2016 | 16:32PM EST
  2. Meet The Stock Mutual Fund That Didn’t Lose Ground In The Week

    IBD | Feb. 16, 2016 | 14:58PM EST
  3. Intercept Pharma Spikes On Report That It’s Exploring A Sale

    IBD | Feb. 12, 2016 | 15:30PM EST
  4. Gilead, Johnson & Johnson or Roche?

    GuruFocus | Feb. 11, 2016 | 12:15PM EST
  5. Benzinga's Top Initiations

    Benzinga | Feb. 11, 2016 | 09:47AM EST
  6. Zika Virus Spreading: Here's How To Play It Again

    Benzinga | Feb. 10, 2016 | 13:49PM EST
  7. Jeff Auxier Takes Plunge in Fastenal, a Stock From Watchlist

    GuruFocus | Feb. 10, 2016 | 12:13PM EST
  8. Icahn, Gilead, GE Lead Top Insider Trades Of The Week

    Benzinga | Feb. 9, 2016 | 16:07PM EST
  9. Cramer Shares His Thoughts On Chipotle Mexican Grill, Inc. And Gilead Sciences, Inc.

    Benzinga | Feb. 9, 2016 | 07:49AM EST
  10. How To Invest In An Aging World With The 'Live Long & Prosper' ETF

    Benzinga | Feb. 8, 2016 | 10:53AM EST
  11. Bill Gates, Apple Chair, Nike CEO Lead Week’s Insider Trades

    IBD | Feb. 5, 2016 | 13:45PM EST
  12. Strong Dollar Pounds S&P 500 Into Earnings Recession

    IBD | Feb. 5, 2016 | 08:02AM EST
  13. Gilead Sciences Rallies Off Q4 Report

    Benzinga | Feb. 3, 2016 | 15:10PM EST
  14. Zika-Related Social Media Chatter Is Picking Up

    Benzinga | Feb. 3, 2016 | 13:40PM EST
  15. Illumina Brings More Pain To Battered Biotech ETFs; Gold Hits High

    IBD | Feb. 3, 2016 | 13:05PM EST
  16. Benzinga's Top Initiations

    Benzinga | Feb. 3, 2016 | 09:45AM EST
  17. Keep an Eye on These 10 Stocks for February 3, 2016

    Benzinga | Feb. 3, 2016 | 04:28AM EST
  18. Gilead Trounces Hep C Estimates; Harvoni International Footprint Nearly Equals U.S.

    Benzinga | Feb. 2, 2016 | 17:17PM EST
  19. Earnings Recap For February 2

    Benzinga | Feb. 2, 2016 | 16:45PM EST
  20. Plenty of Opportunity to Buy Individual Stocks: John Buckingham

    GuruFocus | Feb. 2, 2016 | 12:32PM EST
  21. Apple: Think Differently From the Analysts

    GuruFocus | Feb. 1, 2016 | 15:13PM EST
  22. Gilead Hits New 52-Week Low; Here Are Two Reasons Why

    Benzinga | Jan. 29, 2016 | 13:32PM EST
  23. Worst Performing Industries For January 29, 2016

    Benzinga | Jan. 29, 2016 | 12:08PM EST
  24. 10 Fund Managers Are Totally Wrong on GlaxoSmithKline

    GuruFocus | Jan. 26, 2016 | 14:59PM EST
  25. Gilead Sciences Now Holds 14.75% of Galapagos Shares

    Benzinga | Jan. 25, 2016 | 04:11AM EST
  26. Jim Cramer Dishes On Microsoft, Gilead, TG Therapeutics & NY Community Bancorp

    Benzinga | Jan. 24, 2016 | 19:56PM EST
  27. Gilead Sciences Tumbles; Unconfirmed Reports Of Drug Pricing Changes In Japan

    Benzinga | Jan. 20, 2016 | 12:07PM EST
  28. GILEAD SCIENCES

    IBD | Jan. 19, 2016 | 18:48PM EST
  29. The Best Reason to Love Gilead's Market Correction

    GuruFocus | Jan. 18, 2016 | 16:35PM EST
  30. Rethink U.S. Large-Cap Exposure With This ETF

    Benzinga | Jan. 15, 2016 | 13:25PM EST
  31. Amazon Gets New Call; Disney Downgraded Amid Netflix

    IBD | Jan. 15, 2016 | 09:12AM EST
  32. Gurus Are Buying These Stocks Trading Below Peter Lynch value

    GuruFocus | Jan. 14, 2016 | 17:27PM EST
  33. Galapagos, Gilead Cleared FTC to Close Global Partnership on Filgotinib

    Benzinga | Jan. 13, 2016 | 04:20AM EST
  34. Moving To Momentum With ETFs

    Benzinga | Jan. 12, 2016 | 07:28AM EST
  35. Apple Supplier Avago, Guns, Gilead Top Insider Trades

    IBD | Jan. 8, 2016 | 15:10PM EST
  36. Why Gilead Is 'The Apple Of Biotech'

    Benzinga | Jan. 7, 2016 | 16:36PM EST
  37. Gilead Leads 3 Drug Stocks With Top Fundamentals

    IBD | Jan. 7, 2016 | 08:02AM EST
  38. Jim Cramer Gives His Opinion On Lockheed Martin And Gilead Sciences

    Benzinga | Jan. 7, 2016 | 06:35AM EST
  39. A Calmer Year For Pharma?

    IBD | Jan. 6, 2016 | 18:47PM EST
  40. 3 Potential Blockbuster Drugs Launching in 2016

    IBD | Jan. 6, 2016 | 09:42AM EST
  41. Gilead Sciences

    IBD | Jan. 5, 2016 | 18:56PM EST
  42. Stocks End Mixed; Apple Drops, Macom Hits Sell Signal

    IBD | Jan. 5, 2016 | 16:32PM EST
  43. GILEAD SCIENCES

    IBD | Jan. 4, 2016 | 18:42PM EST
  44. Gilead, Other Biotechs Selling Off On Market Weakness

    Benzinga | Jan. 4, 2016 | 14:22PM EST
  45. Berkshire Hathaway: Dividends Are Coming; Why Not In 2016?

    GuruFocus | Dec. 31, 2015 | 13:06PM EST
  46. Here are My Top Ten Stock Picks for 2016

    GuruFocus | Dec. 30, 2015 | 15:58PM EST
  47. An Award-Winning Debut For This Goldman ETF

    Benzinga | Dec. 23, 2015 | 09:54AM EST
  48. Tesla, First Solar, Gilead Lead Week's Insider Deals

    IBD | Dec. 21, 2015 | 17:50PM EST
  49. Ackman, Sequoia Stock Valeant Changes Course

    GuruFocus | Dec. 18, 2015 | 17:46PM EST
  50. Glaxo's ViiV Acquiring Bristol-Myers' HIV Candidates

    IBD | Dec. 18, 2015 | 14:05PM EST
Trading Center